Detection of DFUs in clinical settings and telemedicine platforms is another game-changer. YOLO (You Only Look Once), Faster ...

Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced it has received U.S. Food ...

Read the Market Summary Here:- https://reportocean.com/industry-verticals/sample-request?report_id=bwcc18603 ...

A news study published in JAMA has determined that daily application of 2% chlorhexidine wipes for foot hygiene in diabetic ...

With a focus on patient-centered care, OWC Center utilizes advanced technologies and evidence-based practices to manage a wide range of wounds, including diabetic foot ulcers, vascular wounds ...

In one advertisement, Fife flagged in 2023, a skin substitute representative whose company name has been redacted boasts of a ...

A civil rights lawsuit involving the death of a Brighton detainee at the Council Jail will move forward, a federal judge has ...

Recce has opted to carry out its phase III diabetic foot injury trial in Indonesia - which looks a safer bet than the US ...

Findings showed treatment with SkinTE plus SOC resulted in more wound closure compared with SOC alone. The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to SkinTE ...

Initiated VALUE, a global Phase III pivotal trial of EscharEx® for venous leg ulcers Expanded strategic research collaborations with industry leaders, now including Kerecis $20 million in revenue for ...

Many people with diabetes develop foot ulcers—open wounds on the feet—that are dangerous because almost half of them become infected. Infections can lead to hospital stays and sometimes force doctors ...

Q4 2024 Results Conference Call March 19, 2025 8:30 AM ETCompany ParticipantsDan Ferry - IR, LifeSci AdvisorsOfer Gonen - ...